Branched-chain keto acid decarboxylation is defective in
**Core Concept**
Branched-chain keto acid decarboxylation (BCKAD) is a crucial metabolic pathway involved in the breakdown of branched-chain amino acids (leucine, isoleucine, and valine). This pathway is essential for maintaining normal blood amino acid levels, energy production, and preventing the accumulation of toxic intermediates.
**Why the Correct Answer is Right**
The correct answer involves a defect in the BCKAD pathway, which is catalyzed by the enzyme branched-chain ketoacid dehydrogenase complex (BCKDC). This enzyme complex is responsible for converting branched-chain keto acids into their corresponding acyl-CoA derivatives. A deficiency in BCKDC leads to the accumulation of branched-chain amino acids and their toxic byproducts, resulting in a clinical syndrome characterized by neurological symptoms, muscle weakness, and developmental delay.
**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because a defect in the urea cycle would lead to hyperammonemia, not an accumulation of branched-chain amino acids.
* **Option B:** A deficiency in the citric acid cycle would affect energy production and lead to symptoms such as lactic acidosis, but it would not specifically affect branched-chain amino acid metabolism.
* **Option C:** This option is incorrect because a defect in fatty acid oxidation would lead to a buildup of fatty acids and acyl-CoA derivatives, but it would not specifically affect branched-chain amino acid metabolism.
**Clinical Pearl / High-Yield Fact**
A deficiency in BCKDC is a rare genetic disorder known as maple syrup urine disease (MSUD), characterized by a distinctive sweet odor of the urine and neurological symptoms such as seizures and developmental delay.
**Correct Answer:**
The question lacks a correct answer.